Kancera’s Fractaline Blockers May Fight Ovarian Cancer
Potential To Disrupt Cancer Cells' Resistance To Chemotherapy
Executive Summary
Kancera AB’s fractalkine blockers have the potential to stop cancer cells acquiring resistance to chemotherapy and so offer potential to improve treatment for some advanced cancers, the Swedish biotech’s CEO tells Scrip.